Anthera, Orexigen Submerge in Monday’s 52-Week Low Club

Print Email

March 12, 2018: Here are four stocks trading with heavy volume among 39 equities making new 52-week lows in Monday’s session. On the NYSE advancers led decliners by around 8 to 7 and on the Nasdaq, advancers led decliners by about the same ratio.

Anthera Pharmaceuticals Inc. (NASDAQ: ANTH) traded down about 85% Monday and posted a new 52-week and all-time low of $0.40 after closing Friday at $2.64. The stock’s 52-week high is $5.60. Volume was more than 30 times the daily average of around 1.7 million shares. The company’s Sollpura treatment failed a phase 3 trial.

Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 78% Monday and posted a new 52-week low of $0.31 after closing Friday at $1.40. The stock’s 52-week high is $4.46. Volume was around 7.5million, about 15 times the daily average. The company has filed for Chapter 11 bankruptcy.

VEON Ltd. (NASDAQ: VEON) fell about 2.2% Monday to match a 52-week low of $2.61 after closing at $2.67 on Friday. The 52-week high is $4.47. Volume of around 6.7 million was about 30% above the daily average. The company had no specific news.

New Gold Inc. (NYSEAMERICAN: NGD) dropped about 2.9% Monday to post a new 52-week low of $2.35. Shares closed at $2.42 on Friday and the stock’s 52-week high is $4.25. Volume was about 10% below the daily average of around 5.8 million shares. The gold mining company had no news.